| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Keros Therapeutics, Inc. | SVP, General Counsel | Common Stock | 44K | $637K | $14.48 | Aug 6, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| KROS | Keros Therapeutics, Inc. | Aug 6, 2025 | 0 | $0 | 3 | Aug 15, 2025 | SVP, General Counsel |